GlaxoSmithKline’s shingles vaccine gets approval in Canada

(Reuters) – Canadian health regulators have approved GlaxoSmithKline’s key shingles vaccine, the company said on Friday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply